Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Discover ways to give back while enjoying your community. This guide pairs volunteering opportunities with free events to help you do more for less.
28,400 articlesA seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
A director sold 45,000 LUMN shares, triggering questions about Lumen Technologies stock sell signals. This article br...
Oil climbs and stock futures rise as renewed U.S.-Iran clashes raise supply disruption fears in the Persian Gulf.
A veteran macro strategist says the classic college route may not pay off for today’s youth. He points to skilled tra...
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
February brought a sharp drop for Upstart as investors weighed margins, product risk, and leadership changes. This de...
Strategy led by Michael Saylor sold a record 3,588 BTC for $216 million, sparking debate about Bitcoin's direction. A...
TAO jumps more than 10% in a single session as Bitcoin targets $72,000. The move sets the tone for a weekend of volat...
Jim Cramer argues that South Korea mispricing SK Hynix reflects trader psychology rather than weak fundamentals. He r...
A stock delivering 81% gains in six months faces another chapter after March 18. This guide breaks down the story, th...
Tesla pushed out a solid delivery quarter, but the stock didn’t follow. This article breaks down what the numbers mea...
Nvidia pulls off a landmark $20B Groq deal that could reshape AI inference in 2026. This piece breaks down the tech, ...